Interim report 1 January – 30 September 2024
Q3 2024: Strong performance in the US THIRD QUARTER 2024…
PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen
MUMBAI, India & HYDERABAD, India: PopVax, an Indian full-stack biotechnology company…
MilDef significantly expands its presence in Central Europe – enters into agreement for a transformative acquisition of roda computer GmbH
MilDef Group AB (publ) (”MilDef”) has, through its wholly owned…
Bitcoin Nears $100K, Enters “Euphoria Zone” as Bullish Sentiment Peaks
Bitcoin Nears $100K, Enters “Euphoria Zone” as Bullish Sentiment Peaks Bitcoin is rapidly advancing toward…
Crypto VC Investment Drops 31.3% in Q3 2024 Amid Market Volatility
Crypto VC Investment Drops 31.3% in Q3 2024 Amid Market Volatility The crypto industry saw…
Analyst Predicts Bitcoin Bull Market Peak in October 2025: What This Means for Investors
Analyst Predicts Bitcoin Bull Market Peak in October 2025: What This Means for Investors -…
Bitcoin Dominance Hits 61% as BTC Strengthens Its Hold on the Crypto Market
Bitcoin Dominance Hits 61% as BTC Strengthens Its Hold on the Crypto Market Bitcoin’s market…
Genius Group Shares Surge 66% Following Commitment to “Bitcoin-First” Strategy
Genius Group Shares Surge 66% Following Commitment to "Bitcoin-First" Strategy - BitcoinWorld Skip to content…